BusinessPhoto: Business StandardSun Pharma Board Approves ₹10,000 Crore Fundraising via NCDs
Sun Pharmaceutical Industries' board approved raising up to ₹10,000 crore through non-convertible debentures (NCDs) in a meeting held on October 12. The NCDs will be listed, rated, unsecured, and redeemable, issued via private placement in one or more tranches. Additionally, Gautam Doshi resigned as a Non-Executive Independent Director, stepping down from all board committees due to personal reasons.
Business Standard·



